@FiercePharma: Big Pharma pressures U.K. officials on cancer drug use as special fund set to expire. More from PMLiVE | Follow @FiercePharma
@EricPFierce: COPD market is growing rapidly but so is the number of drugs approved to treat it. Novartis gets in. Story | Follow @EricPFierce
> Sanofi's ($SNY) Genzyme unit sued Indian generics maker Dr. Reddy's Laboratories to defend its patents on the cancer drug Mozobil. Report
> GW Pharmaceuticals said German pricing authorities agreed to a new, higher price for Sativex, a treatment for multiple sclerosis symptoms. Report
> Perrigo recruited a former FDA official to head up its regulatory review activities. Report
> Supernus Pharmaceuticals ($SUPN) designated Catalent Pharma Solutions as its supplier for delayed-release technology employed in a recently launched epilepsy treatment. Report | More from FierceCRO
> The United Nations said there has been dramatic progress in the worldwide fight against AIDS, thanks to the growing availability of treatment. Report
@FierceMedDev: Veracyte, a molecular diagnostic company, has filed plans for an IPO. Story | Follow @FierceMedDev
@DamianFierce: FDA device chief Jeffrey Shuren blogs about "landmark" UDI rule. More | Follow @DamianFierce
@MarkHFierce: RainDance, a maker of gene-sequencing tools, raised up to $35M in debt financing to keep the sales push going. Article | Follow @MarkHFierce
@MichaelGFierce: ICYMI: Bind collects $70.5M IPO to support Accurin tech. More from FierceDrugDelivery | Follow @MichaelGFierce
> SafeShot pulls in $9M to develop better pre-filled syringes. More
> AdvaMed: Medical device prices have plunged. News
> Report: Med tech industry on growth track despite obstacles. Item
Biotech News
@FierceBiotech: ICYMI Friday: San Diego biotech insider accused of shooting RNAi expert and brother-in-law. Article | Follow @FierceBiotech
@JohnCFierce: Perlmutter has been working hard to create a new narrative for Merck R&D. More efficient, smarter, focused on winners. Legacy bites again. | Follow @JohnCFierce
@EmilyMFierce: NIH launches $45M Alzheimer's research effort, awards funds to 3 preclinical studies. Story from FierceBiotech Research | Follow @EmilyMFierce
> Biotech public records spur 'arms race' for investors. Article
> Merck R&D hammered by another setback as FDA rejects anesthesia drug (again). Story
> Roche lung cancer drug bags another 'breakthrough' at the FDA. News
> Ablynx lands $840M AbbVie deal on next-gen Humira successor. Article
CRO News
> Quintiles seals deal for Novella. News
> PPD lures UCB exec to head immunology. Report
> Capsugel expands in U.S., Europe. Item
> CMO Aesica puts up $48M to make diabetes drugs. Article
> Catalent lands manufacturing deal with Supernus. More
> InVentiv partners up for policy, site selection. Story
Biotech IT News
> BRAIN Initiative prioritizes better data storage and analysis. More
> Biotech broker fined $5,000 for venting on Facebook. Item
> FDA posts final guidance on electronic source data. Story
> Google hires ex-Genentech CEO to lead ambitious bio spinoff. Report
> Bioinformatics-driven Eisai subsidiary inks discovery alliance. News
> New York Genome Center opens $54M biomedical-research hub. Article
And Finally... Homeless patients have sued Nevada, saying the state mental hospital shipped them out of state to avoid paying for their care. Report (sub. req.)